CMV-specific STAR fusions (Altor bioscience)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NameCMV-specific STAR fusions (Altor bioscience)

Drug Alias NameSTAR fusions agents (Altor)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugateBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionT lymphocytes modulators

TargetsUpdating

Therapy Area/IndicationsCytomegalovirus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAltor Bioscience Corp

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAltor Bioscience Corp

Active IndicationsN/A

Inactive IndicationsCytomegalovirus Infections

Other Information

ATC CodeN/A